Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

The World Health Organization is developing a global strategy to eliminate cervical cancer, with goals for screening prevalence among women aged 30 through 49 years. However, evidence on prevalence levels of cervical cancer screening in low- and middle-income countries (LMICs) is sparse. To determin...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:JAMA : the journal of the American Medical Association Ročník 324; číslo 15; s. 1532
Hlavní autori: Lemp, Julia M, De Neve, Jan-Walter, Bussmann, Hermann, Chen, Simiao, Manne-Goehler, Jennifer, Theilmann, Michaela, Marcus, Maja-Emilia, Ebert, Cara, Probst, Charlotte, Tsabedze-Sibanyoni, Lindiwe, Sturua, Lela, Kibachio, Joseph M, Moghaddam, Sahar Saeedi, Martins, Joao S, Houinato, Dismand, Houehanou, Corine, Gurung, Mongal S, Gathecha, Gladwell, Farzadfar, Farshad, Dryden-Peterson, Scott, Davies, Justine I, Atun, Rifat, Vollmer, Sebastian, Bärnighausen, Till, Geldsetzer, Pascal
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 20.10.2020
Predmet:
Adult
Cross-Sectional Studies
Developing Countries
Early Detection of Cancer - statistics & numerical data
Female
Global Health
Health Care Surveys
Humans
Middle Aged
Patient Acceptance of Health Care - statistics & numerical data
Self Report
Uterine Cervical Neoplasms - diagnosis
ISSN:1538-3598, 1538-3598
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:The World Health Organization is developing a global strategy to eliminate cervical cancer, with goals for screening prevalence among women aged 30 through 49 years. However, evidence on prevalence levels of cervical cancer screening in low- and middle-income countries (LMICs) is sparse. To determine lifetime cervical cancer screening prevalence in LMICs and its variation across and within world regions and countries. Analysis of cross-sectional nationally representative household surveys carried out in 55 LMICs from 2005 through 2018. The median response rate across surveys was 93.8% (range, 64.0%-99.3%). The population-based sample consisted of 1 136 289 women aged 15 years or older, of whom 6885 (0.6%) had missing information for the survey question on cervical cancer screening. World region, country; countries' economic, social, and health system characteristics; and individuals' sociodemographic characteristics. Self-report of having ever had a screening test for cervical cancer. Of the 1 129 404 women included in the analysis, 542 475 were aged 30 through 49 years. A country-level median of 43.6% (interquartile range [IQR], 13.9%-77.3%; range, 0.3%-97.4%) of women aged 30 through 49 years self-reported to have ever been screened, with countries in Latin America and the Caribbean having the highest prevalence (country-level median, 84.6%; IQR, 65.7%-91.1%; range, 11.7%-97.4%) and those in sub-Saharan Africa the lowest prevalence (country-level median, 16.9%; IQR, 3.7%-31.0%; range, 0.9%-50.8%). There was large variation in the self-reported lifetime prevalence of cervical cancer screening among countries within regions and among countries with similar levels of per capita gross domestic product and total health expenditure. Within countries, women who lived in rural areas, had low educational attainment, or had low household wealth were generally least likely to self-report ever having been screened. In this cross-sectional study of data collected in 55 low- and middle-income countries from 2005 through 2018, there was wide variation between countries in the self-reported lifetime prevalence of cervical cancer screening. However, the median prevalence was only 44%, supporting the need to increase the rate of screening.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1538-3598
1538-3598
DOI:10.1001/jama.2020.16244